SMX (Security Matters) Public Limited Company Class A Ordinary Shares (SMX) has had the highest return between November 7, 2025 and December 7, 2025 by a US stock, returning 2,180.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
SMX (Security Matters) Public Limited Company Class A Ordinary Shares (SMX) | 11/7/2025 - 12/7/2025 | 2,180.08% |
Galecto (GLTO) | 11/7/2025 - 12/7/2025 | 441.62% |
Magnitude International Ltd Ordinary Shares (MAGH) | 11/7/2025 - 12/7/2025 | 372.73% |
Capricor Therapeutics (CAPR) | 11/7/2025 - 12/7/2025 | 328.18% |
Mersana Therapeutics (MRSN) | 11/7/2025 - 12/7/2025 | 247.19% |
Olema Pharmaceuticals (OLMA) | 11/7/2025 - 12/7/2025 | 231.83% |
Guild Holdings (GHLD) | 11/7/2025 - 12/7/2025 | 231.08% |
Palatin Technologies (PTNT) | 11/7/2025 - 12/7/2025 | 186.65% |
Beachbody Company, Inc Class A Common Stock (BODI) | 11/7/2025 - 12/7/2025 | 174.8% |
Cogent Biosciences (COGT) | 11/7/2025 - 12/7/2025 | 164.1% |
Quince Therapeutics (QNCX) | 11/7/2025 - 12/7/2025 | 155.41% |
CCH Holdings Ltd Ordinary Shares (CCHH) | 11/7/2025 - 12/7/2025 | 152.09% |
Verrica Pharmaceuticals (VRCA) | 11/7/2025 - 12/7/2025 | 151% |
PACS (PACS) | 11/7/2025 - 12/7/2025 | 147.07% |
Q/C Technologies (QCLS) | 11/7/2025 - 12/7/2025 | 145.52% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 11/7/2025 - 12/7/2025 | 141.2% |
Annovis Bio (ANVS) | 11/7/2025 - 12/7/2025 | 138.22% |
Alumis (ALMS) | 11/7/2025 - 12/7/2025 | 137.61% |
NUVB-WT (NUVB.WT) | 11/7/2025 - 12/7/2025 | 132.45% |
Cidara Therapeutics (CDTX) | 11/7/2025 - 12/7/2025 | 124.19% |
TryHard Holdings Limited Ordinary Shares (THH) | 11/7/2025 - 12/7/2025 | 122.09% |
Rain Enhancement Technologies Holdco, Inc Warrants (RAINW) | 11/7/2025 - 12/7/2025 | 116.27% |
Fossil (FOSL) | 11/7/2025 - 12/7/2025 | 108.89% |
Ridgetech (RDGT) | 11/7/2025 - 12/7/2025 | 105.56% |
Spruce Power (SPRU) | 11/7/2025 - 12/7/2025 | 103.85% |
